AJMedP-3 medical intelligence doctrine

What it is

AJMedP-3, Allied Joint Medical Publication 3, is NATO's doctrine for medical intelligence. The document defines medical intelligence as intelligence "derived from medical, bio-scientific, epidemiological, environmental and other information related to human or animal health," and its purpose is to describe to commanders and staff what medical intelligence can do for them. It implements STANAG 2547, the NATO agreement under which nations commit to running a medical intelligence programme: AJMedP-3 is the doctrine that programme runs on, not a separate agreement nations ratify on their own account.

Who it addresses

The document is explicit that it "is principally for use by NATO commanders and their medical and intelligence staffs in the planning and conduct of campaigns, operations, and exercises," while also having "utility for a wide range of other users, especially for medical personnel at every level of command." It focuses mainly on the operational level, as the interface between individual Allied and multinational forces. It also extends to coalition settings: it applies equally to "operations conducted by a Coalition of NATO and non-NATO nations" under a NATO-led Combined Joint Task Force, or to European-led operations using NATO assets and capabilities. It does not address a supplier, a manufacturer or a national procurement authority, and it creates no obligation that a company holds directly.

How it sits in NATO's doctrine hierarchy

AJMedP-3 does not stand alone. Its Foreword places it under NATO's intelligence policy in AJP-2.0, which sets out how the intelligence cycle works, and under NATO's medical policy in AJP 4.10, which the Foreword calls the "capstone" document for medical guidance. It also sits under a Military Committee policy cited as MC 65-7. MC 326 is cited as setting the role of medical intelligence within the force protection concept, and Bi-SC Directive 65-7 is cited as providing the conceptual background for medical intelligence management and the production of doctrine and training within NATO. A supporting document, SRD-1 to AJMedP-3, the "Guide to medical intelligence handbook," elaborates the framework this publication sets out. None of MC 65-7, MC 326, Bi-SC Directive 65-7, AJP-2.0 or AJP 4.10 is in our catalogue, so they are named here without a link.

What the document covers

At subject level, AJMedP-3 covers three things: definitions, organisation, and the place of medical intelligence in planning. It fixes medical intelligence, medical information, health hazard, health threat and health risk as distinct working terms, and it is explicit that medical intelligence is the analysed product, while medical information is the underlying data "that has not been analysed for intelligence purposes." It describes medical intelligence as relevant to the assessment of health risks, the formation of medical estimates, preventive medicine planning, and the ongoing management of medical support, across the strategic, operational and tactical levels of planning, for the range of health hazards, including disease, that a deployed force can meet in an area of operations. It sets out a Medical Intelligence Officer function within the NATO Command Structure: a dedicated full-time post at ACO/SHAPE and Joint Force Command level, and an additional duty at tactical or service command level, working alongside the intelligence (J2) staff.

What it does not cover

The document stays at doctrine and organisation. It states plainly that "NATO member nations will not collect medical intelligence on other NATO members," a restriction worth noting because it runs against the assumption that medical intelligence means watching anyone of interest, allies included. It does not itself set out disease or hazard specifics, threat assessments, or the methods by which medical intelligence is collected: those questions belong to the classified and operational products the doctrine describes the use of, not to this publication.

How you are evaluated

AJMedP-3 names no certification, audit or inspection scheme, and no body is described as assessing a nation's or a company's compliance with it. The only review mechanism in the document is NATO reviewing its own text: it is "a living document" reviewed regularly under NATO's standardisation procedures, with the Military Committee Medical Standardisation Board holding tasking authority over updates. That is not an assessment of anyone's conformity to the doctrine.